Identification and quantification of differentially expressed proteins in plasma of spinocerebellar ataxia type 12

Neuroscience Research

Volumn 73, Issue 2, 2012, Pages 161-167

  Swarup, Vishnu ^a   Srivastava, Achal K ^a   Rajeswari, Moganty R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Neurological disorders; Proteomics; Spinocerebellar ataxia type 12

Indexed keywords

APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; DNA; HAPTOGLOBIN; HEMOGLOBIN; NUCLEIC ACID BINDING PROTEIN; PREALBUMIN; RETINOL; SPINOCEREBELLAR ATAXIA 12; THYROXINE; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADULT; ARTICLE; CAG REPEAT; COGNITIVE DEFECT; DNA SEQUENCE; FEMALE; HUMAN; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MEMORY; NEUROPATHY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SPINOCEREBELLAR DEGENERATION;

ADULT; BLOOD PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MIDDLE AGED; NERVE TISSUE PROTEINS; PROTEIN PHOSPHATASE 2; PROTEOMICS; SPINOCEREBELLAR ATAXIAS;

EID: 84860323048     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2012.03.002     Document Type: Article

References (31)

1. Adornato B.T., Engel W.K., Foidart-Desalle M. Elevations of hemopexin levels in neuromuscular disease. Arch. Neurol. 1978, 35:577-580.
2. Bahl S., Virdi K., Mittal U., Sachdeva M.P., Kalla A.K., Holmes S.E., O'Hearn E., Margolis R.L., Jain S., Srivastava A.K., Mukerji M. Evidence of a common founder for SCA12 in the Indian population. Ann. Hum. Genet. 2005, 69:528-534.
3. Baldo-Enzi G., Bernardo M., Vitale E., Baiocchi M.R., Trevisan C., Micaglio G.F., Angelini C., Fellin R., Crepaldi G. Serum lipids, lipoprotein analysis and apoprotein A-I, A-II and B levels in Friedreich's ataxia. Eur. Neurol. 1990, 30:5667-5672.
4. Bird, T.D., 2011. Hereditary ataxia overview. (modified July 2011). http://www.ncbi.nlm.nih.gov/books/NBK1138/.
5. Dagda R.K., Merrill R.A., Cribbs J.T., Chen Y., Hell J.W., Usachev Y.M., Strack S. The spinocerebellar ataxia 12 gene product and protein phosphatase 2A regulatory subunit Bbeta2 antagonizes neuronal survival by promoting mitochondrial fission. J. Biol. Chem. 2008, 283:36241-36248.
6. Dueñas A.M., Goold R., Giunti P. Molecular pathogenesis of spinocerebellar ataxias. Brain 2006, 129:1357-1370.
7. Durr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol. 2010, 9:885-894.
8. Faruq M., Scaria V., Singh I., Tyagi S., Srivastava A.K., Mukerji M. SCA-LSVD: a repeat-oriented locus-specific variation database for genotype to phenotype correlations in spinocerebellar ataxias. Hum. Mutat. 2009, 30:1037-1042.
9. Ferrigno P., Langan T.A., Cohen P. Protein phosphatase 2A1 is the major enzyme in vertebrate cell extracts that dephosphorylates several physiological substrates for cyclin-dependent protein kinases. Mol. Biol. Cell 1993, 4:669-677.
10. Fleming C.E., Mar F.M., Franquinho F., Sousa M.M. Chapter 17. Transthyretin: an enhancer of nerve regeneration. Int. Rev. Neurobiol. 2009, 87:337-346.
11. Freeman W.M., Hemby S.E. Proteomics for protein expression profiling in neuroscience. Neurochem. Res. 2004, 29:1065-1081.
12. Fujigasaki H., Verma I.C., Camuzat A., Margolis R.L., Zander C., Lebre A.S., Jamot L., Saxena R., Anand I., Holmes S.E., Ross C.A., Dürr A., Brice A. SCA12 is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian family. Ann. Neurol. 2001, 49:117-121.
13. Guéye P.M., Glasser N., Férard G., Lessinger J.M. Influence of human haptoglobin polymorphism on oxidative stress induced by free hemoglobin on red blood cells. Clin. Chem. Lab. Med. 2006, 44:542-547.
14. Holmes S.E., O'Hearn E.E., McInnis M.G., Gorelick-Feldman D.A., Kleiderlein J.J., Callahan C., Kwak N.G., Ingersoll-Ashworth R.G., Sherr M., Sumner A.J., Sharp A.H., Ananth U., Seltzer W.K., Boss M.A., Vieria-Saecker A.M., Epplen J.T., Riess O., Ross C.A., Margolis R.L. Expansion of a novel CAG trinucleotide repeat in the 5' region of PPP2R2B is associated with SCA12. Nat. Genet. 1999, 23:391-392.
15. Holmes S.E., Hearn E.O., Ross C.A., Margolis R.L. SCA12: an unusual mutation leads to an unusual spinocerebellar ataxia. Brain Res. Bull. 2001, 56:397-403.
16. Holmes S.E., O'Hearn E., Margolis R.L. Why is SCA12 different from other SCAs?. Cytogenet. Genome Res. 2003, 100:189-197.
17. Immenschuh S., Song D.X., Satoh H., Muller-Eberhard U. The type II hemopexin interleukin-6 response element predominates the transcriptional regulation of the hemopexin acute phase responsiveness. Biochem. Biophys. Res. Commun. 1995, 207:202-208.
18. Kanika N.D., Tar M., Tong Y., Kuppam D.S., Melman A., Davies K.P. The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathway. Am. J. Physiol. Cell Physiol. 2009, 297:C916-C927.
19. Liu C.C., Manzi S., Danchenko N., Ahearn J.M. New advances in measurement of complement activation: lessons of systemic lupus erythematosus. Curr. Rheumatol. Rep. 2004, 6:375-381.
20. O'Hearn E. SCA12: tremor with cerebellar and cortical atrophy is associated with a CAG repeat expansion. Neurology 2001, 56:299-303.
21. Sadrzadeh S.M., Bozorgmehr J. Haptoglobin phenotypes in health and disorders. Am. J. Clin. Pathol. 2004, 121(Suppl.):S97-S104.
22. Sanchez D.J., Armstrong L., Aguilar R., Adrian G.S., Haro L., Martinez A.O. Haptoglobin gene expression in human glioblastoma cell lines. Neurosci. Lett. 2001, 303:181-184.
23. Sinha K.K. Spinocerebellar ataxia-12 (SCA12): a tremor dominant disease, typically seen in India. Med. Update 2005, 5:600-602.
24. Sinha K.K., Ranjan S., Jha D.K. Spinocerebellar ataxia type 12 is not an uncommon form of ADCA in India. Ann. Ind. Acad. Neurol. 2003, 6:193.
25. Sinha K.K., Worth P.F., Jha D.K., Sinha S., Stinton V.J., Davis M.B., Wood N.W., Sweeney M.G., Bhatia K.P. Autosomal dominant cerebellar ataxia: SCA2 is the most frequent mutation in eastern India. J. Neurol. Neurosurg. Psychiatry 2004, 75:448-452.
26. Srivastava A.K., Choudhry S., Gopinath M.S., Roy S., Tripathi M., Brahmachari S.K., Jain S. Molecular and clinical correlation in five Indian families with spinocerebellar ataxia 12. Ann. Neurol. 2001, 50:796-800.
27. Storey E., Tuck K., Hester R., Hughes A., Churchyard A. Inter-rater reliability of the International Cooperative Ataxia Rating Scale (ICARS). Mov. Disord. 2004, 19:190-192.
28. Swarup V., Srivastava A.K., Padma M.V., Rajeswari M.R. Quantification of circulating plasma DNA in Friedreich's ataxia and spinocerebellar ataxia types 2 and 12. DNA Cell Biol. 2011, 30:389-394.
29. Teunissen C.E., van Boxtel M.P., Bosma H., Bosmans E., Delanghe J., De Bruijn C., Wauters A., Maes M., Jolles J., Steinbusch H.W., de Vente J. Inflammation markers in relation to cognition in a healthy aging population. J. Neuroimmunol. 2003, 134:142-150.
30. Trouillas P., Takayanagi T., Hallett M., Currier R.D., Subramony S.H., Wessel K., Bryer A., Diener H.C., Massaquoi S., Gomez C.M., Coutinho P., Ben Hamida M., Campanella G., Filla A., Schut L., Timann D., Honnorat J., Nighoghossian N., Manyam B. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. the Ataxia Neuropharmacology Committee of the World Federation of Neurology. J. Neurol. Sci. 1997, 145:205-211.
31. Wang Y.C., Lee C.M., Lee L.C., Tung L.C., Hsieh-Li H.M., Lee-Chen G.J., Su M.T. Mitochondrial dysfunction and oxidative stress contribute to the pathogenesis of spinocerebellar ataxia type 12 (SCA12). J. Biol. Chem. 2011, 286:21742-21754.